{"id":"https://openalex.org/W3215549329","doi":"https://doi.org/10.14283/jpad.2021.61","title":"A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease","display_name":"A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease","publication_year":2021,"publication_date":"2021-11-19","ids":{"openalex":"https://openalex.org/W3215549329","doi":"https://doi.org/10.14283/jpad.2021.61","mag":"3215549329","pmid":"https://pubmed.ncbi.nlm.nih.gov/35542997"},"language":"en","primary_location":{"id":"doi:10.14283/jpad.2021.61","doi":"https://doi.org/10.14283/jpad.2021.61","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2021.61","pdf_url":"https://link.springer.com/content/pdf/10.14283/jpad.2021.61.pdf","source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.14283/jpad.2021.61.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059020389","display_name":"Lon S. S. Schneider","orcid":"https://orcid.org/0000-0002-4636-6150","observed_orcids":["https://orcid.org/0000-0002-4636-6150"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"L.S. Schneider","raw_affiliation_strings":["Lon S. Schneider, Department of Psychiatry and the Behavioral Sciences, and Department of Neurology, Keck School of Medicine, and Leonard Davis School of Gerontology of the University of Southern California, Los Angeles, CA, USA, lschneid@usc.edu","Department of Psychiatry and the Behavioral Sciences, and Department of Neurology, Keck School of Medicine, and Leonard Davis School of Gerontology of the University of Southern California, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lon S. Schneider, Department of Psychiatry and the Behavioral Sciences, and Department of Neurology, Keck School of Medicine, and Leonard Davis School of Gerontology of the University of Southern California, Los Angeles, CA, USA, lschneid@usc.edu","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"Department of Psychiatry and the Behavioral Sciences, and Department of Neurology, Keck School of Medicine, and Leonard Davis School of Gerontology of the University of Southern California, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076836777","display_name":"Moshe Laudon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104281","display_name":"Neurim Pharmaceuticals (Israel)","ror":"https://ror.org/01gd1jq14","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210104281"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"M. Laudon","raw_affiliation_strings":["Neurim Pharmaceuticals Ltd, Tel Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurim Pharmaceuticals Ltd, Tel Aviv, Israel","institution_ids":["https://openalex.org/I4210104281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051986478","display_name":"Tali Nir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104281","display_name":"Neurim Pharmaceuticals (Israel)","ror":"https://ror.org/01gd1jq14","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210104281"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"T. Nir","raw_affiliation_strings":["Neurim Pharmaceuticals Ltd, Tel Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurim Pharmaceuticals Ltd, Tel Aviv, Israel","institution_ids":["https://openalex.org/I4210104281"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Caceres","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Caceres","raw_affiliation_strings":["Dante Labs, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dante Labs, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"G. Ianniciello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Ianniciello","raw_affiliation_strings":["Dante Labs, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dante Labs, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024526919","display_name":"Mattia Capulli","orcid":"https://orcid.org/0000-0003-0449-6720","observed_orcids":["https://orcid.org/0000-0003-0449-6720"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Capulli","raw_affiliation_strings":["Dante Labs, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dante Labs, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048778691","display_name":"Nava Zisapel","orcid":"https://orcid.org/0000-0001-6098-2868","observed_orcids":["https://orcid.org/0000-0001-6098-2868"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I4210104281","display_name":"Neurim Pharmaceuticals (Israel)","ror":"https://ror.org/01gd1jq14","country_code":"IL","type":"company","lineage":["https://openalex.org/I4210104281"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"N. Zisapel","raw_affiliation_strings":["Department of Neurobiology, Faculty of Life Sciences, Tel-Aviv University, Tel Aviv, Israel","Neurim Pharmaceuticals Ltd, Tel Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurobiology, Faculty of Life Sciences, Tel-Aviv University, Tel Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]},{"raw_affiliation_string":"Neurim Pharmaceuticals Ltd, Tel Aviv, Israel","institution_ids":["https://openalex.org/I4210104281"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5059020389"],"corresponding_institution_ids":["https://openalex.org/I1174212"],"apc_list":{"value":2780,"currency":"USD","value_usd":2780},"apc_paid":{"value":2780,"currency":"USD","value_usd":2780},"fwci":1.6817,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.83149929,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":98},"biblio":{"volume":"9","issue":"2","first_page":"247","last_page":"254"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.4894999861717224,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.4894999861717224,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.4480000138282776,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.02500000037252903,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mild-alzheimer-s-disease","display_name":"mild Alzheimer's disease","score":0.9319999814033508},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.972000002861023},{"id":"https://openalex.org/keywords/genetic-predictors-of-treatment-response","display_name":"genetic predictors of treatment response","score":0.734000027179718},{"id":"https://openalex.org/keywords/melatonin-receptor-agonists","display_name":"melatonin receptor agonists","score":0.7400000095367432},{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.640999972820282},{"id":"https://openalex.org/keywords/5-ht1d-receptor","display_name":"5-HT1D receptor","score":0.8169999718666077},{"id":"https://openalex.org/keywords/sleep-quality","display_name":"sleep quality","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C84597430","wikidata":"https://www.wikidata.org/wiki/Q106227","display_name":"Locus (genetics)","level":3,"score":0.6965986490249634},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6494511365890503},{"id":"https://openalex.org/C164866538","wikidata":"https://www.wikidata.org/wiki/Q367351","display_name":"Cluster (spacecraft)","level":2,"score":0.5027077198028564},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.40167680382728577},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38736167550086975},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2702554166316986},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25344449281692505},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1216069757938385},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.08183741569519043},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055106","descriptor_name":"Genome-Wide Association Study","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.14283/jpad.2021.61","doi":"https://doi.org/10.14283/jpad.2021.61","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2021.61","pdf_url":"https://link.springer.com/content/pdf/10.14283/jpad.2021.61.pdf","source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},{"id":"pmid:35542997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35542997","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of prevention of Alzheimer's disease","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.14283/jpad.2021.61","doi":"https://doi.org/10.14283/jpad.2021.61","is_oa":true,"landing_page_url":"https://doi.org/10.14283/jpad.2021.61","pdf_url":"https://link.springer.com/content/pdf/10.14283/jpad.2021.61.pdf","source":{"id":"https://openalex.org/S4210234663","display_name":"The Journal of Prevention of Alzheimer s Disease","issn_l":"2274-5807","issn":["2274-5807","2426-0266"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Prevention of Alzheimer's Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3215549329.pdf","grobid_xml":"https://content.openalex.org/works/W3215549329.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1164896577","https://openalex.org/W1977733462","https://openalex.org/W1996776294","https://openalex.org/W2007947662","https://openalex.org/W2024719735","https://openalex.org/W2028428817","https://openalex.org/W2032883444","https://openalex.org/W2052796829","https://openalex.org/W2072533873","https://openalex.org/W2078516327","https://openalex.org/W2109031511","https://openalex.org/W2131584217","https://openalex.org/W2151487996","https://openalex.org/W2153203890","https://openalex.org/W2326999214","https://openalex.org/W2606894917","https://openalex.org/W2980705117","https://openalex.org/W2986164211","https://openalex.org/W3129455513"],"related_works":["https://openalex.org/W2070181801","https://openalex.org/W7100259881","https://openalex.org/W2924417929","https://openalex.org/W4401382138","https://openalex.org/W2166280481","https://openalex.org/W2136975096","https://openalex.org/W2131485213","https://openalex.org/W2054423190","https://openalex.org/W4250854501","https://openalex.org/W2980466215"],"abstract_inverted_index":{"BACKGROUND:":[0],"Piromelatine":[1],"is":[2],"a":[3,19,102,111,157,304],"novel":[4],"melatonin":[5],"MT1/2/3":[6],"and":[7,29,57,69,76,115,151,253,281],"serotonin":[8],"5-HT-1A/1D":[9],"receptors":[10],"agonist":[11],"developed":[12],"for":[13,33,180,295,311],"mild":[14,39,296],"Alzheimer's":[15],"disease":[16],"(AD).":[17],"In":[18],"randomized,":[20],"placebo-controlled,":[21],"dose-ranging":[22],"study":[23,90,192],"(ReCognition)":[24],"of":[25,110,226,232,293,316],"piromelatine":[26,56,98,242,261,272,294],"(5,":[27],"20,":[28],"50":[30],"mg":[31,274],"daily":[32],"6":[34],"months)":[35],"in":[36,146,165,173,194,206,303],"participants":[37,170],"with":[38,212,260,271,278],"dementia":[40],"due":[41],"to":[42,200,245,263],"AD":[43,308],"(n=371,":[44],"age":[45],"60-85":[46],"years),":[47],"no":[48],"statistically":[49],"significant":[50],"differences":[51],"were":[52,83,171,210],"found":[53],"between":[54],"the":[55,61,147,166,174,190,224,227,233,239,251,266,317],"placebo-treated":[58],"groups":[59],"on":[60,136,238,241,250,265],"primary":[62],"(i.e.,":[63,141],"computerized":[64],"neuropsychological":[65],"test":[66,133],"battery":[67],"(cNTB))":[68],"secondary":[70],"outcomes":[71],"(ADCS-CGIC,":[72],"ADCS-MCI-ADL,":[73],"ADAS-cog14,":[74],"NPI,":[75],"Pittsburgh":[77],"Sleep":[78],"Quality":[79],"Index":[80],"(PSQI))":[81],"nor":[82],"there":[84],"safety":[85],"concerns":[86],"(https://clinicaltrials.gov/ct2/show/NCT02615002).":[87],"OBJECTIVES:":[88],"This":[89],"was":[91,119,134],"aimed":[92],"at":[93],"identifying":[94],"genetic":[95],"markers":[96],"predicting":[97],"treatment":[99],"response":[100,199,213],"using":[101,121,156],"genome-wide":[103],"association":[104],"approach":[105],"(GWAS).":[106],"DESIGN:":[107],"Variant":[108],"genotyping":[109],"combined":[112],"whole":[113,116],"genome":[114],"exome":[117],"sequencing":[118],"performed":[120,135],"DNA":[122],"extracted":[123],"from":[124,126,144,189],"lymphocytes":[125],"consenting":[127],"participants.":[128],"The":[129,183,284],"general":[130],"case-control":[131],"allelic":[132],"piromelatine-treated":[137],"participants,":[138],"taking":[139],"\"responders\"":[140],">0.125":[142],"change":[143],"baseline":[145,196],"cNTB)":[148],"as":[149,154,243],"cases":[150],"\"non":[152],"responders\"":[153],"controls,":[155],"Cochran-Armitage":[158],"trend":[159],"test.":[160],"SETTING:":[161],"58":[162],"outpatient":[163],"clinics":[164],"US.":[167],"PARTICIPANTS:":[168],"371":[169],"randomized":[172],"trial;":[175],"107":[176],"provided":[177],"informed":[178],"consent":[179],"genotyping.":[181],"RESULTS:":[182],"GWAS":[184,234],"sample":[185],"did":[186],"not":[187],"differ":[188],"full":[191],"cohort":[193],"demographics,":[195],"characteristics,":[197],"or":[198],"piromelatine.":[201],"Six":[202],"single-nucleotide":[203],"polymorphisms":[204],"(SNPs)":[205],"chromosome":[207],"2q12":[208,228,285,318],"(2:107,510,000-107,540,000)":[209,286],"associated":[211],"(p-value":[214],"<":[215],"1x10":[216],"-4":[217],"each).":[218],"Post":[219],"hoc":[220],"analyses":[221],"suggested":[222],"that":[223],"carriers":[225],"polymorphism":[229,319],"cluster":[230,289],"(27%":[231],"sample)":[235],"improved":[236,258],"significantly":[237,248,259],"cNTB":[240],"compared":[244,262],"placebo":[246,264,279],"but":[247],"worsened":[249],"ADAS-Cog14":[252,267],"PSQI.":[254,282],"By":[255],"contrast,":[256],"\"non-carriers\"":[257],"(":[268],"2.91":[269],"(N=23)":[270],"20":[273],"vs":[275],"1.65":[276],"(N=19)":[277],"(p=0.03))":[280],"CONCLUSIONS:":[283],"5-6":[287],"SNPs":[288],"may":[290],"predict":[291],"efficacy":[292],"AD.":[297],"These":[298],"findings":[299],"warrant":[300],"further":[301],"investigation":[302],"larger,":[305],"prospective":[306],"early-stage":[307],"clinical":[309],"trial":[310],"patients":[312],"who":[313],"are":[314],"non-carriers":[315],"cluster.":[320]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-12-06T00:00:00"}